Common ailment and non-prescription medication-related problems faced by people with intellectual disability: Findings from medication reviews provided by pharmacists

IF 3.4 3区医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Research in Social & Administrative Pharmacy Pub Date : 2026-01-01 Epub Date: 2025-09-13 DOI:10.1016/j.sapharm.2025.09.001

Chelsea Felkai , Jamie-Lee Carew , David Newby , Joyce Cooper , Hayley Croft

{"title":"Common ailment and non-prescription medication-related problems faced by people with intellectual disability: Findings from medication reviews provided by pharmacists","authors":"Chelsea Felkai , Jamie-Lee Carew , David Newby , Joyce Cooper , Hayley Croft","doi":"10.1016/j.sapharm.2025.09.001","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Pharmacists in Australia play a significant role in managing non-prescription medicines and common ailments. The aims of this research were to describe the medication related issues people with intellectual disability face with their common ailments and non-prescription medications and document the recommendations made by pharmacists as part of the medication review process.</div></div><div><h3>Method</h3><div>A retrospective analysis of medication review reports from credentialed pharmacists performed for a person with intellectual disability between January 2020 and January 2024.</div></div><div><h3>Results</h3><div>A total of 80 reports were analysed with an average of 6.6 common ailments and 8.0 non-prescription medications per individual with ID. The credentialed pharmacists identified an average of 3.6 issues related to their common ailment or non-prescription medication.</div></div><div><h3>Conclusion</h3><div>People with intellectual disability have significant issues managing common ailments and non-prescription medicines, that could potentially be more appropriately managed in the primary care setting.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 1","pages":"Pages 128-134"},"PeriodicalIF":3.4000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research in Social & Administrative Pharmacy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1551741125004498","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/13 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}

引用次数: 0

Abstract

Background

Pharmacists in Australia play a significant role in managing non-prescription medicines and common ailments. The aims of this research were to describe the medication related issues people with intellectual disability face with their common ailments and non-prescription medications and document the recommendations made by pharmacists as part of the medication review process.

Method

A retrospective analysis of medication review reports from credentialed pharmacists performed for a person with intellectual disability between January 2020 and January 2024.

Results

A total of 80 reports were analysed with an average of 6.6 common ailments and 8.0 non-prescription medications per individual with ID. The credentialed pharmacists identified an average of 3.6 issues related to their common ailment or non-prescription medication.

Conclusion

People with intellectual disability have significant issues managing common ailments and non-prescription medicines, that could potentially be more appropriately managed in the primary care setting.

查看原文本刊更多论文

智力残疾者面临的常见疾病和非处方药相关问题；药剂师提供的药物审查结果。

背景：澳大利亚的药剂师在管理非处方药和常见疾病方面发挥着重要作用。本研究的目的是描述智障患者在常见疾病和非处方药方面面临的药物相关问题，并记录药剂师在药物审查过程中提出的建议。方法：回顾性分析2020年1月至2024年1月间执业药师对1例智障患者的药物评价报告。结果：共分析了80份报告，平均每个ID患者6.6种常见疾病和8.0种非处方药。有资格的药剂师平均发现了3.6个与他们的常见病或非处方药有关的问题。结论：智障人士在处理常见病和非处方药方面存在重大问题，这些问题可能在初级保健机构得到更适当的管理。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Research in Social & Administrative Pharmacy PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-

CiteScore

7.20

自引率

10.30%

发文量

225

审稿时长

47 days

期刊介绍： Research in Social and Administrative Pharmacy (RSAP) is a quarterly publication featuring original scientific reports and comprehensive review articles in the social and administrative pharmaceutical sciences. Topics of interest include outcomes evaluation of products, programs, or services; pharmacoepidemiology; medication adherence; direct-to-consumer advertising of prescription medications; disease state management; health systems reform; drug marketing; medication distribution systems such as e-prescribing; web-based pharmaceutical/medical services; drug commerce and re-importation; and health professions workforce issues.